<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="decrease">
            <roleset id="decrease.02" name="" wordnet="1">
                <roles>
                    <role n="0" descr="theme&#x0A;" />
                    <role n="2" descr="amount decreased &#x09;&#x09;&#x09;&#x0A;" />
                    <role n="1" descr="location&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>Also, is the CD3 statement shown to be decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                </example>
                <example src="EGRAM" no="1">
                    <text>By contrast, GP is able to decrease only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>By contrast, GP is predicted that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>Concomitantly, acetycoline levels are able to decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Concomitantly, acetycoline levels can decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Concomitantly, acetycoline levels can decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Concomitantly, acetycoline levels could decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Concomitantly, acetycoline levels decreased by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Concomitantly, acetycoline levels decreased in 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Concomitantly, acetycoline levels decreases by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>Concomitantly, acetycoline levels have decreased by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>Concomitantly, acetycoline levels may have decreased by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>Concomitantly, acetycoline levels may have decreased in 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Concomitantly, acetycoline levels was able to decrease in 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Concomitantly, acetycoline levels was shown to decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Concomitantly, acetycoline levels were able to decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Concomitantly, acetycoline levels will decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>Concomitantly, acetycoline levels will have decreased in 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Concomitantly, acetycoline levels would decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>Concomitantly, acetylcholine levels decreased by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>Concomitantly, acetylcholine levels decreases by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>Concomitantly, acetylcholine levels is able to decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>Concomitantly, acetylcholine levels may decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>Concomitantly, acetylcholine levels may decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>Concomitantly, acetylcholine levels may have decreased by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>Concomitantly, acetylcholine levels will decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>Concomitantly, acetylcholine levels would decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>Concomitantly, acetylcholine levels would have decreased by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>Concomitantly, it was predicted that acetycoline levels will decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>Concomitantly, it was predicted that acetycoline levels would decrease in 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>Concomitantly, it was shown that acetycoline levels decreases by 37.8% in lead animals treated with lead decrease to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>In addition, CD3 expression could decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>In addition, CD3 expression has the ability to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                </example>
                <example src="EGRAM" no="33">
                    <text>In addition, CD3 expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                </example>
                <example src="EGRAM" no="34">
                    <text>In addition, CD3 expression? is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>In addition, CD3 expression? would decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>In addition, CD3? expression can decrease by mixing normal T cells with TBM-M? depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>In addition, CD3? expression can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>In addition, CD3? expression can decrease with normal T-cell blending with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>In addition, CD3? expression could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>In addition, CD3? expression could decrease by mixing normal T cells with TBM-M?s in a number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>In addition, CD3? expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>In addition, CD3? expression has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>In addition, CD3? expression has decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>In addition, CD3? expression is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>In addition, CD3? expression may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>In addition, CD3? expression may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>In addition, CD3? expression was able to decrease by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>In addition, CD3? expression will decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>In addition, CD3? expression will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>In addition, CD3? expression would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>In addition, it has been decrease that CD3? expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>In addition, it is decrease that CD3? expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>In addition, the CD3 expression has the ability to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent (Fig.2B) way.</text>
                </example>
                <example src="EGRAM" no="54">
                    <text>In addition, the CD3 expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent (Fig.2B) way.</text>
                </example>
                <example src="EGRAM" no="55">
                    <text>In addition, the CD3? expression decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>In addition, the CD3? expression is decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                </example>
                <example src="EGRAM" no="57">
                    <text>In addition, the expression CD3? was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>In addition, the expression of CD3? can be decreased by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>In addition, the expression of CD3? expression decreases with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>In addition, the expression of CD3? is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>In addition, the expression of CD3? will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>In contrast, G may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>In contrast, GP is able to decrease only only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>In contrast, GP is predicted that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>In contrast, GP may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>In contrast, GP may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>In contrast, GP was decreased by the reduction of only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>In contrast, GP was demonstrated by only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>In contrast, GP will only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>In contrast, PG could decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>In contrast, PG decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>In contrast, PG is found to decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) A1 (in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>In contrast, PG may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>In contrast, PG may have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>In contrast, PG showed that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>In contrast, PG showed that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>In contrast, PG was found to decrease 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) A1 (in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>In contrast, PG was predicted for only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>In contrast, PG will decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>In contrast, PG would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>Instead, GP decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>Instead, GP may have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>Instead, GP was decreased by decreased only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>Instead, GP would have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>Instead, GP would have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>Instead, PG can decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>Instead, PG can decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>Instead, PG is found to decrease only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) A1 (in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>Instead, PG was found to decrease 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) A1 (in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>Instead, PG would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
